BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 739446)

  • 1. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia.
    Ichimaru M; Ishimaru T; Belsky JL
    J Radiat Res; 1978 Sep; 19(3):262-82. PubMed ID: 739446
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autopsy study of leukemia in atomic bomb survivors, Hiroshima-Nagasaki, 1949-1969.
    Liu PI; Ishimaru T; McGregor DH; Yamamoto T; Steer A
    Cancer; 1973 Jun; 31(6):1315-27. PubMed ID: 4513690
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. D. Leukemia and related disorders.
    Ichimaru M; Ishimaru T
    J Radiat Res; 1975 Sep; 16 Suppl():89-96. PubMed ID: 1104825
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 6. An epidemiological study on leukemia in survivors exposed to the atomic bomb in childhood in Hiroshima. I.
    Shimizu K
    Hiroshima J Med Sci; 1968 Sep; 17(3):123-9. PubMed ID: 5717115
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukemia: lessons from the Japanese experience.
    Finch SC
    Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964. I. Distribution, incidence and appearance time.
    Bizzozero OJ; Johnson KG; Ciocco A
    N Engl J Med; 1966 May; 274(20):1095-101. PubMed ID: 5932020
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950--30 September 1966.
    Ishimaru T; Hoshino T; Ichimaru M; Okada H; Tomiyasu T
    Radiat Res; 1971 Jan; 45(1):216-33. PubMed ID: 5275936
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignancies in atomic bomb survivors in Hiroshima and Nagasaki.
    Shimaoka K; Akiba S
    J Nucl Med Allied Sci; 1990; 34(4):254-9. PubMed ID: 2090789
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69.
    McGregor H; Land CE; Choi K; Tokuoka S; Liu PI; Wakabayashi T; Beebe GW
    J Natl Cancer Inst; 1977 Sep; 59(3):799-811. PubMed ID: 894745
    [No Abstract]   [Full Text] [Related]  

  • 12. A long-term cohort study of the atomic-bomb survivors.
    Kodama K; Mabuchi K; Shigematsu I
    J Epidemiol; 1996 Aug; 6(3 Suppl):S95-105. PubMed ID: 8800280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation.
    Shimizu Y; Schull WJ; Kato H
    JAMA; 1990 Aug; 264(5):601-4. PubMed ID: 2366300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia in offspring of atomic bomb survivors.
    Hoshino T; Kato H; Finch SC; Hrubec Z
    Blood; 1967 Dec; 30(6):719-30. PubMed ID: 6077425
    [No Abstract]   [Full Text] [Related]  

  • 15. Occupational factors in the epidemiology of leukemia in Hiroshima and Nagasaki.
    Ishimaru T; Okada H; Tomiyasu T; Tsuchimoto T; Hoshino T; Ichimaru M
    Am J Epidemiol; 1971 Mar; 93(3):157-65. PubMed ID: 5556392
    [No Abstract]   [Full Text] [Related]  

  • 16. The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945-1965.
    Nishiyama H; Anderson RE; Ishimaru T; Ishida K; Ii Y; Okabe N
    Cancer; 1973 Dec; 32(6):1301-9. PubMed ID: 4757920
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-related leukemia in Hiroshima and Nagasaki 1946--1964. II.
    Bizzozero OJ; Johnson KG; Ciocco A; Kawasaki S; Toyoda S
    Ann Intern Med; 1967 Mar; 66(3):522-30. PubMed ID: 5226879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.